enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

3. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   The most common side effects of these drugs that led to withdrawals were mental disturbances, cardiac side effects, and drug abuse or drug dependence. Deaths were associated with seven products. [85] Ephedra was removed from the US market in 2004 over concerns that it raises blood pressure and could lead to strokes and death. [86]

4. Which Medications Are FDA-Approved for Weight Loss? - AOL

   www.aol.com/lifestyle/medications-fda-approved...

   There are seven FDA-approved weight loss medications currently available. These medications are safe and effective and have minimal side effects. ... These medications are safe and effective and ...

5. Obesity drug Wegovy is approved to cut heart attack and ...

   www.aol.com/news/obesity-drug-wegovy-approved...

   The weight-loss drug typically costs about $1,300 a month. Novo Nordisk has also asked European Union regulators to expand the use of the drug for heart problems. EU regulators have not weighed in ...

6. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors ...

7. Wegovy and other weight loss drugs shows promise for heart ...

   www.aol.com/news/wegovy-shows-promise-heart...

   The weight-loss drug Wegovy can reduce the risk of heart attacks and strokes by 20% in adults with heart disease and obesity, according to new research.. The trial is the first to show that a ...